BRCA2 and hereditary breast ovarian cancer syndrome: As suggested by Pritchard (2019) [19] the terminology of the syndrome itself—BRCA1- and BRCA2-associated Hereditary Breast and Ovarian Cancer syndrome–is considered misleading and should be changed because it induces the false belief that BRCA1/2 mutations are "women’s business" only.